John H. Tucker
2020
In 2020, John H. Tucker earned a total compensation of $1.7M as President and Chief Executive Officer at scPharmaceuticals, a 40% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $238,860 |
|---|---|
| Option Awards | $957,238 |
| Salary | $530,800 |
| Other | $10,803 |
| Total | $1,737,701 |
Tucker received $957.2K in option awards, accounting for 55% of the total pay in 2020.
Tucker also received $238.9K in non-equity incentive plan, $530.8K in salary and $10.8K in other compensation.
Rankings
In 2020, John H. Tucker's compensation ranked 6,174th out of 13,090 executives tracked by ExecPay. In other words, Tucker earned more than 52.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,174 out of 13,090 | 53rd |
Division Manufacturing | 2,551 out of 5,621 | 55th |
Major group Chemicals And Allied Products | 1,027 out of 2,254 | 54th |
Industry group Drugs | 886 out of 1,954 | 55th |
Industry Pharmaceutical Preparations | 661 out of 1,459 | 55th |
Source: SEC filing on April 27, 2021.
Tucker's colleagues
We found one more compensation record of an executive who worked with John H. Tucker at scPharmaceuticals in 2020.
2020
Rachael Nokes
scPharmaceuticals
Senior Vice President of Finance
News
scPharmaceuticals CEO John Tucker's 2022 pay slips 14% to $1.6M
April 27, 2023
scPharmaceuticals CEO John Tucker's 2021 pay rises 7% to $1.9M
April 28, 2022
scPharmaceuticals CEO John Tucker's 2020 pay jumps 40% to $1.7M
April 27, 2021
scPharmaceuticals CEO John Tucker's 2019 pay slips 17% to $1.2M
April 27, 2020
scPharmaceuticals CEO John Tucker's 2018 pay falls 25% to $1.5M
April 30, 2019